Clinical trials update: highlights of the scientific sessions of the XXIII Congress of the European Society of Cardiology--WARIS II, ESCAMI, PAFAC, RITZ-1 and TIME.

This publication has 9 references indexed in Scilit:

• Endothelin antagonists for chronic heart failure: do they have a role?
  Published by Oxford University Press (OUP) ,2001
• Representation of Elderly Persons and Women in Published Randomized Trials of Acute Coronary Syndromes
  JAMA, 2001
• Clinical Trials Update: CAPRICORN, COPERNICUS, MIRACLE, STAF, RITZ‐2, RECOVER and RENAISSANCE and cachexia and cholesterol in heart failure. Highlights of the Scientific Sessions of the American College of Cardiology, 2001
  European Journal of Heart Failure, 2001
• Trial of Invasive versus Medical Therapy in the Elderly (TIME)
  Heart Drug, 2001
• Evaluation of the Safety and Cardioprotective Effects of Eniporide, a Specific Sodium/Hydrogen Exchange Inhibitor, Given as Adjunctive Therapy to Reperfusion in Patients with Acute Myocardial Infarction
  Heart Drug, 2001
• Clinical trials update: highlights of the scientific sessions of the American Heart Association year 2000: Val HeFT, COPERNICUS, MERIT, CIBIS‐II, BEST, AMIOVIRT, V‐MAC, BREATHE, HEAT, MIRACL, FLORIDA, VIVA and the first human cardiac skeletal muscle myoblast transfer for heart failure
  European Journal of Heart Failure, 2001
• Clinical trials update: IMPROVEMENT‐HF, COPERNICUS, MUSTIC, ASPECT‐II, APRICOT and HEART
  European Journal of Heart Failure, 2000
• Effects of Warfarin, Aspirin and the Two Combined, on Mortality and Thromboembolic Morbidity after Myocardial Infarction: The WARIS-II (Warfarin-Aspirin Reinfarction Study) Design
  Scandinavian Cardiovascular Journal, 2000
• Die medikamentöse Prophylaxe nach elektronischer Kardioversion von chronischem Vorhofflimmern
  Clinical Research in Cardiology, 1999